TTIC
GSK icon

Tower Trust & Investment Company’s GSK GSK Stock Holding History

Tower Trust & Investment Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
22,861
-146
-0.6% -$7.72K 0.73% 27
2026
Q1 		$1.27M Buy
23,007
+43
+0.2% +$2.33K 0.83% 27
2025
Q4 		$1.13M Sell
22,964
-231
-1% -$10.8K 0.71% 35
2025
Q3 		$1M Buy
23,195
+293
+1% +$11.4K 0.67% 34
2025
Q2 		$879K Buy
22,902
+621
+3% +$23.7K 0.62% 42
2025
Q1 		$888K Buy
+22,281
New +$816K 0.72% 36

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Tower Trust & Investment Company's GSK Position: Q2 2026 in Review

Tower Trust & Investment Company reduced its GSK (GSK) stake by 0.63% in Q2 2026, selling an estimated $7.72K and leaving 22,861 shares worth $1.2M. The position accounts for 0.73% of the portfolio, ranked #27.

Tower Trust & Investment Company first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.27M in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Tower Trust & Investment Company held 22,861 shares of GSK worth $1.2M as of Q2 2026.
  • Tower Trust & Investment Company sold 146 GSK shares in Q2 2026, an estimated $7.72K.
  • GSK made up 0.73% of Tower Trust & Investment Company's portfolio in Q2 2026, its #27 holding.
  • Tower Trust & Investment Company first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
  • Tower Trust & Investment Company's GSK position peaked at $1.27M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.